Are Wearables Worthy for Regulated Clinical Trials?
Industry Experts Bust the Myths of 'Validation'
Covid-19 and the imminent rise of 5G networks are an accelerant to advancing wearables for clinical trials, deepening our commitment to tracking better digital endpoints.
But in our collective rush to run trials virtually, we must validate that the new devices and wearable solutions are appropriate and accurate. In this webinar, Ariel Dowling, Takeda; Abhi Verma, Novartis; VP of Science and Research Kate Lyden, VivoSense, and Jeremy Wyatt, Actigraph; share essential guidelines to start with the end in mind and take a comprehensive approach to managing complexity and best practice implementation that will maximize the value of your data in the long term.
Explore wearable sensor solutions for your regulated clinical trial.